Fatty acid-conjugated radiopharmaceuticals for fibroblast activation protein-targeted radiotherapy.
Pu ZhangMengxin XuJie DingJunyi ChenTaiping ZhangLi HuoZhibo LiuPublished in: European journal of nuclear medicine and molecular imaging (2021)
This proof-of-concept study validates the hypothesis that conjugation of albumin binders may shift the pharmacokinetics and enhance the tumor uptake of FAPI-based radiopharmaceuticals. This could be a general strategy to transform the diagnostic FAP-targeted radiopharmaceuticals into their therapeutic pairs.